Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines.
effectiveness
influenza virus
vaccine
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
01 May 2022
01 May 2022
Historique:
received:
01
04
2022
revised:
28
04
2022
accepted:
29
04
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Influenza is a vaccine preventable disease and vaccination remains the most effective method of controlling the morbidity and mortality of seasonal influenza, especially with respect to risk groups. To date, three types of influenza vaccines have been licensed: inactivated, live-attenuated, and recombinant haemagglutinin vaccines. Effectiveness studies allow an assessment of the positive effects of influenza vaccines in the field. The effectiveness of current influenza is suboptimal, being estimated as 40% to 60% when the vaccines strains are antigenically well-matched with the circulating viruses. This review focuses on influenza viruses and vaccines and the role of vaccine effectiveness studies for evaluating the benefits of influenza vaccines. Overall, influenza vaccines are effective against morbidity and mortality in all age and risk groups, especially in young children and older adults. However, the effectiveness is dependent on several factors such as the age of vaccinees, the match between the strain included in the vaccine composition and the circulating virus, egg-adaptations occurring during the production process, and the subject's history of previous vaccination.
Identifiants
pubmed: 35632470
pii: vaccines10050714
doi: 10.3390/vaccines10050714
pmc: PMC9143275
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Cochrane Database Syst Rev. 2018 Feb 01;2:CD004879
pubmed: 29388195
Vaccines (Basel). 2021 Sep 17;9(9):
pubmed: 34579269
Am J Epidemiol. 2012 Sep 15;176(6):527-33
pubmed: 22940713
Front Immunol. 2021 Oct 06;12:744774
pubmed: 34691051
J Infect Dis. 2018 Jul 2;218(3):347-354
pubmed: 29506129
J Infect Dis. 2019 Apr 19;219(10):1586-1595
pubmed: 30496437
Euro Surveill. 2021 Sep;26(36):
pubmed: 34505568
Exp Mol Med. 2021 May;53(5):737-749
pubmed: 33953324
Vaccines (Basel). 2018 May 21;6(2):
pubmed: 29883414
N Engl J Med. 2017 Jun 22;376(25):2427-2436
pubmed: 28636855
Nat Commun. 2019 Jul 26;10(1):3338
pubmed: 31350391
Expert Rev Vaccines. 2010 Oct;9(10):1127-33
pubmed: 20923264
Emerg Infect Dis. 2006 Jan;12(1):9-14
pubmed: 16494710
Lancet Infect Dis. 2016 Aug;16(8):942-51
pubmed: 27061888
N Engl J Med. 2014 Apr 3;370(14):1335-42
pubmed: 24693893
Emerg Infect Dis. 2008 Aug;14(8):1187-92
pubmed: 18680640
BMC Infect Dis. 2019 Nov 21;19(1):990
pubmed: 31752738
Open Forum Infect Dis. 2021 Feb 05;8(3):ofab069
pubmed: 33738320
Expert Rev Vaccines. 2016 Aug;15(8):967-76
pubmed: 26954563
Vaccine. 2018 Feb 28;36(10):1272-1278
pubmed: 29402578
J Virol. 2014 Jul;88(14):7692-5
pubmed: 24789791
Biotechnol J. 2015 May;10(5):702-14
pubmed: 25800821
J Biol Chem. 2010 Sep 10;285(37):28411-7
pubmed: 20538599
Hum Vaccin Immunother. 2012 Jan;8(1):81-8
pubmed: 22252006
Ther Adv Vaccines. 2015 Jul;3(4):97-108
pubmed: 26478817
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3645-6
pubmed: 19276125
Clin Infect Dis. 2021 Aug 2;73(3):497-505
pubmed: 32505128
Am J Infect Control. 2020 Dec;48(12):1422-1425
pubmed: 32442653
R Soc Open Sci. 2021 Mar 24;8(3):201433
pubmed: 33959318
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Jun 6;53(6):576-580
pubmed: 31177753
Vaccine. 2020 Mar 23;38(14):2893-2903
pubmed: 32113808
Front Pediatr. 2019 Jul 30;7:317
pubmed: 31417886
N Engl J Med. 2009 Nov 12;361(20):1945-52
pubmed: 19745214
Vaccines (Basel). 2020 Nov 07;8(4):
pubmed: 33171854
Vaccines (Basel). 2020 Jul 23;8(3):
pubmed: 32718039
JAMA. 2007 Apr 11;297(14):1577-82
pubmed: 17426277
Expert Rev Vaccines. 2019 Jul;18(7):737-750
pubmed: 31265333
Vaccine. 2009 Nov 5;27(47):6589-94
pubmed: 19716456
Vaccine. 2022 Jan 28;40(4):621-626
pubmed: 34952756
Int J Infect Dis. 2019 Nov;88:127-134
pubmed: 31401203
Vaccine. 2003 Mar 7;21(11-12):1268-74
pubmed: 12559808
PLoS One. 2021 Aug 27;16(8):e0256165
pubmed: 34450617
Vaccines (Basel). 2021 Dec 07;9(12):
pubmed: 34960193
BMC Infect Dis. 2017 Dec 29;17(1):805
pubmed: 29284435
Methods Mol Biol. 2012;865:147-62
pubmed: 22528158
Expert Rev Vaccines. 2017 Jul;16(7):1-14
pubmed: 28562111
Curr Opin Immunol. 2014 Aug;29:38-42
pubmed: 24769424
J Am Geriatr Soc. 2011 Feb;59(2):327-32
pubmed: 21275932
Vaccine. 2011 Mar 9;29(12):2272-8
pubmed: 21277410
J Infect Dis. 2006 May 1;193(9):1223-8
pubmed: 16586358
Cell. 2016 Jul 28;166(3):609-623
pubmed: 27453470
NPJ Vaccines. 2021 Aug 24;6(1):108
pubmed: 34429431
Vaccines (Basel). 2021 Aug 05;9(8):
pubmed: 34451987
JAMA. 2007 May 9;297(18):2025-7
pubmed: 17488968
Euro Surveill. 2016;21(14):
pubmed: 27101732
Front Microbiol. 2017 Jun 23;8:1041
pubmed: 28690590
Vaccine. 2014 Sep 22;32(42):5496-502
pubmed: 25131727
NPJ Vaccines. 2019 Jul 9;4:28
pubmed: 31312528
Clin Infect Dis. 2021 Sep 7;73(5):816-823
pubmed: 33605977
N Engl J Med. 2018 Jan 4;378(1):7-9
pubmed: 29185857
Am J Epidemiol. 2018 Feb 1;187(2):389-397
pubmed: 28641373
Am J Epidemiol. 2011 Jul 1;174(1):109-17
pubmed: 21602300
Vaccines (Basel). 2021 Dec 31;10(1):
pubmed: 35062721
Mayo Clin Proc. 2010 Mar;85(3):257-73
pubmed: 20118381
Int J Infect Dis. 2020 Oct;99:199-203
pubmed: 32717398
J Infect. 2017 Nov;75(5):381-394
pubmed: 28935236
Viruses. 2020 Jan 13;12(1):
pubmed: 31941041
Vaccine. 2016 May 5;34(21):2460-2465
pubmed: 27016650
Vaccine. 2020 Aug 27;38(38):6047-6056
pubmed: 32600916
Lancet Infect Dis. 2012 Sep;12(9):687-95
pubmed: 22738893
Viruses. 2019 Dec 27;12(1):
pubmed: 31892120
Hum Vaccin Immunother. 2018 Jun 3;14(6):1323-1330
pubmed: 29461909
Vaccines (Basel). 2021 Aug 02;9(8):
pubmed: 34451971
Elife. 2020 Oct 13;9:
pubmed: 33048046
Vaccines (Basel). 2015 Mar 18;3(1):172-85
pubmed: 26344952
Clin Infect Dis. 2002 May 1;34 Suppl 2:S58-64
pubmed: 11938498
Front Microbiol. 2021 Nov 11;12:737216
pubmed: 34858361
Vaccine. 2011 Oct 13;29(44):7733-9
pubmed: 21835220
J Infect Dis. 2021 Sep 1;224(5):813-820
pubmed: 33378531
Transbound Emerg Dis. 2022 Jan 23;:
pubmed: 35067005
Epidemiol Infect. 2018 Jan;146(1):78-88
pubmed: 29208075
Clin Infect Dis. 2022 Jan 13;:
pubmed: 35024795
Clin Infect Dis. 2016 Jul 1;63(1):21-32
pubmed: 27025838
Methods Mol Biol. 2011;665:161-81
pubmed: 21116801
Nat Rev Immunol. 2019 Jun;19(6):383-397
pubmed: 30837674
Vaccines (Basel). 2021 Sep 24;9(10):
pubmed: 34696176
PLoS Med. 2006 Apr;3(4):e89
pubmed: 16509764
Clin Transl Immunology. 2021 Jun 13;10(6):e1297
pubmed: 34136219
Int J Infect Dis. 2019 Nov;88:113-119
pubmed: 31401200
J Infect Dis. 2006 Nov 15;194(10):1394-7
pubmed: 17054068
Lancet Respir Med. 2017 Mar;5(3):200-211
pubmed: 28189522
Influenza Other Respir Viruses. 2016 Sep;10(5):354-60
pubmed: 27426005
Environ Health Perspect. 2011 Apr;119(4):439-45
pubmed: 21097384
J Infect Dis. 2021 Dec 24;:
pubmed: 34951451
J Med Virol. 2022 Jun;94(6):2855-2859
pubmed: 34811769
Vaccine. 2020 May 6;38(21):3759-3765
pubmed: 32276801
J Virol. 2007 Jun;81(11):5429-36
pubmed: 17182688
MMWR Morb Mortal Wkly Rep. 2009 May 22;58(19):521-4
pubmed: 19478718
Ann Fam Med. 2019 Jan;17(1):7-13
pubmed: 30670389